Condition: End Stage Renal Disease · Sponsor: Mario Negri Institute for Pharmacological Research
This is a prospective non-pharmacological interventional study aimed at investigating the relationship between the blood flow condition and the arteriovenous fistula (AVF) sound, with the ultimate aim of predicting the AVF clinical, in patients with end-stage renal disease (ESRD) who require the creation of a vascular access for extracorporeal circulation.
This description comes directly from the study's public registry record.
Michela Bozzetto · +3903545351 · michela.bozzetto@marionegri.it
Always discuss trial participation with your own doctor first.
| A.O. Papa Giovanni XXIII - U.O. Nefrologia e Dialisi | Bergamo, Bergamo, Italy | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06411353